SI2755669T1 - Cynara scolymus extracts and their use for the treatment of metabolic syndrome and dyslipidaemia - Google Patents

Cynara scolymus extracts and their use for the treatment of metabolic syndrome and dyslipidaemia

Info

Publication number: SI2755669T1
Authority: SI; Slovenia
Prior art keywords: dyslipidaemia; treatment; metabolic syndrome; cynara scolymus; scolymus extracts
Prior art date: 2011-09-16

Application number

SI201230953A

Other languages

Slovenian (sl)

Inventor

Ezio Bombardelli

Original Assignee

Indena S.P.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-09-16

Filing date

2012-09-13

Publication date

2017-06-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44907959&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2755669(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-09-13 Application filed by Indena S.P.A. filed Critical Indena S.P.A.

2017-06-30 Publication of SI2755669T1 publication Critical patent/SI2755669T1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Mycology (AREA)
Medical Informatics (AREA)
Botany (AREA)
Alternative & Traditional Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Nutrition Science (AREA)
Child & Adolescent Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Furan Compounds (AREA)

SI201230953A 2011-09-16 2012-09-13 Cynara scolymus extracts and their use for the treatment of metabolic syndrome and dyslipidaemia SI2755669T1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IT001670A ITMI20111670A1 (en)	2011-09-16	2011-09-16	CYNARA SCOLIMUS EXTRACTS FOR THE TREATMENT OF DYSLIPIDEMIES
EP12769052.7A EP2755669B1 (en)	2011-09-16	2012-09-13	Cynara scolymus extracts and their use for the treatment of metabolic syndrome and dyslipidaemia
PCT/EP2012/067889 WO2013037857A1 (en)	2011-09-16	2012-09-13	Cynara scolymus extracts for the treatment of dyslipidaemia

Publications (1)

Publication Number	Publication Date
SI2755669T1 true SI2755669T1 (en)	2017-06-30

Family

ID=44907959

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI201230953A SI2755669T1 (en)	2011-09-16	2012-09-13	Cynara scolymus extracts and their use for the treatment of metabolic syndrome and dyslipidaemia

Country Status (22)

Country	Link
US (1)	US9687468B2 (en)
EP (1)	EP2755669B1 (en)
JP (2)	JP2014526486A (en)
KR (1)	KR102026993B1 (en)
CN (2)	CN111184754A (en)
AR (1)	AR087878A1 (en)
AU (1)	AU2012307404B2 (en)
BR (1)	BR112014004532B1 (en)
CA (1)	CA2845708C (en)
CL (1)	CL2014000595A1 (en)
ES (1)	ES2629186T3 (en)
HK (1)	HK1198935A1 (en)
HU (1)	HUE035035T2 (en)
IL (1)	IL231497B (en)
IT (1)	ITMI20111670A1 (en)
MX (1)	MX349587B (en)
PL (1)	PL2755669T3 (en)
PT (1)	PT2755669T (en)
RU (1)	RU2608459C2 (en)
SG (1)	SG11201400618XA (en)
SI (1)	SI2755669T1 (en)
WO (1)	WO2013037857A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20121570A1 (en) *	2012-09-20	2014-03-21	Indena Spa	NEW EXTRACTS OF CYNARA SCOLIMUS, COFFEA SPP. AND EUROPEAN OLEA FOR THE TREATMENT OF METABOLIC SYNDROME
FR3042413B1 (en)	2015-10-20	2019-07-12	Valbiotis	COMPOSITION COMPRISING A MIXTURE OF MOLECULES EXTRACTED FROM CHRYSANTHELLUM INDICUM AND CYNARA SCOLYMUS AND USE FOR ACTING ON GLUCIDIC AND / OR LIPID METABOLISM
CN108142881A (en) *	2018-03-20	2018-06-12	爱可道生物科技有限公司	A kind of arithoke alabastrum extract blood pressure lowering capsule product and its production technology
WO2021220050A1 (en) *	2020-05-01	2021-11-04	Health And Happiness (H&H) Hong Kong Limited	New compositions useful for treating elevated blood lipid levels

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19627376A1 (en) *	1996-07-06	1998-01-08	Aar Pharma Adler Apotheke	Use of Artichoke (Cynara) extracts
EP0958828A1 (en) *	1998-05-22	1999-11-24	Greither, Peter	Artichoke containing preparation especially for use as medicaments or nutritional supplement
US6162438A (en) *	1999-06-24	2000-12-19	Chromak Research, Inc.	Herbal compositions and their use as agents for control of hypertension, hypercholesterolemia and hyperlipidemia
DE10164893B4 (en) *	2001-08-08	2008-08-28	Divapharma Chur Ag	Process for the preparation of artichoke leaf extracts and thus obtained artichoke leaf extracts
CN100496525C (en) *	2004-04-02	2009-06-10	李嫦梅	Technique of extracting acitve ingredient from roots, stems and leaves from artichoke and application
ITMI20051347A1 (en) *	2005-07-14	2007-01-15	Indena Spa	CYNARA SCOLIMUS EXTRACTS THEIR USE AND FORMULATIONS THAT CONTAIN THEM
EP1967199A1 (en) *	2007-03-07	2008-09-10	Indena S.P.A.	Cynara scolymus extracts and compositions containing them
CA2680076A1 (en) *	2007-03-07	2008-09-12	Indena S.P.A.	Cynara scolymus extracts and compositions containing them
US20080220096A1 (en) *	2007-03-07	2008-09-11	Indena S. P. A.	Cynara scolymus extracts and compositions containing them
WO2009100970A1 (en) *	2008-02-14	2009-08-20	Swiss Caps Rechte Und Lizenzen Ag	Administration form containing preparations made of solanum melongena and cynara scolymus
BRPI1006915B8 (en) *	2009-01-20	2021-05-25	Indena Spa	composition comprising lipophilic extract of zingiber officinale and extract of cynara scolymus, and its use
EP2345646A1 (en) *	2010-01-14	2011-07-20	InterMed Discovery GmbH	Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions

2011
- 2011-09-16 IT IT001670A patent/ITMI20111670A1/en unknown
2012
- 2012-09-13 CN CN202010082048.7A patent/CN111184754A/en active Pending
- 2012-09-13 KR KR1020147006758A patent/KR102026993B1/en not_active Expired - Fee Related
- 2012-09-13 MX MX2014003050A patent/MX349587B/en active IP Right Grant
- 2012-09-13 BR BR112014004532-1A patent/BR112014004532B1/en not_active IP Right Cessation
- 2012-09-13 CN CN201280044558.9A patent/CN103874498A/en active Pending
- 2012-09-13 AU AU2012307404A patent/AU2012307404B2/en not_active Ceased
- 2012-09-13 SG SG11201400618XA patent/SG11201400618XA/en unknown
- 2012-09-13 WO PCT/EP2012/067889 patent/WO2013037857A1/en not_active Ceased
- 2012-09-13 US US14/342,593 patent/US9687468B2/en active Active
- 2012-09-13 EP EP12769052.7A patent/EP2755669B1/en active Active
- 2012-09-13 HU HUE12769052A patent/HUE035035T2/en unknown
- 2012-09-13 CA CA2845708A patent/CA2845708C/en active Active
- 2012-09-13 PL PL12769052T patent/PL2755669T3/en unknown
- 2012-09-13 ES ES12769052.7T patent/ES2629186T3/en active Active
- 2012-09-13 PT PT127690527T patent/PT2755669T/en unknown
- 2012-09-13 SI SI201230953A patent/SI2755669T1/en unknown
- 2012-09-13 HK HK14112568.1A patent/HK1198935A1/en unknown
- 2012-09-13 RU RU2014109450A patent/RU2608459C2/en active
- 2012-09-13 JP JP2014530201A patent/JP2014526486A/en active Pending
- 2012-09-14 AR ARP120103396A patent/AR087878A1/en unknown
2014
- 2014-03-12 CL CL2014000595A patent/CL2014000595A1/en unknown
- 2014-03-13 IL IL231497A patent/IL231497B/en active IP Right Grant
2017
- 2017-06-30 JP JP2017129373A patent/JP6335373B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP2017165783A (en)	2017-09-21
CN111184754A (en)	2020-05-22
BR112014004532B1 (en)	2022-02-22
EP2755669A1 (en)	2014-07-23
JP6335373B2 (en)	2018-05-30
CA2845708A1 (en)	2013-03-21
IL231497B (en)	2019-07-31
AU2012307404B2 (en)	2017-05-25
HUE035035T2 (en)	2018-05-02
US20140228428A1 (en)	2014-08-14
US9687468B2 (en)	2017-06-27
PT2755669T (en)	2017-06-30
WO2013037857A1 (en)	2013-03-21
ITMI20111670A1 (en)	2013-03-17
AU2012307404A1 (en)	2014-03-06
MX2014003050A (en)	2014-04-10
SG11201400618XA (en)	2014-05-29
JP2014526486A (en)	2014-10-06
CN103874498A (en)	2014-06-18
KR20140067044A (en)	2014-06-03
KR102026993B1 (en)	2019-09-30
CA2845708C (en)	2019-11-12
AR087878A1 (en)	2014-04-23
BR112014004532A2 (en)	2017-03-28
CL2014000595A1 (en)	2014-11-14
MX349587B (en)	2017-08-03
HK1198935A1 (en)	2015-06-19
ES2629186T3 (en)	2017-08-07
RU2608459C2 (en)	2017-01-18
RU2014109450A (en)	2015-10-27
EP2755669B1 (en)	2017-04-05
IL231497A0 (en)	2014-04-30
PL2755669T3 (en)	2017-09-29

Publication	Publication Date	Title
BR112014009634A2 (en)	2017-05-09	preparation and therapeutic agent
IL231536A (en)	2016-09-29	Indazole-3-carboxamides , pharmaceutical compositions comprising them and their use in the treatment of diseases
EP2847152A4 (en)	2016-03-23	Compositions and methods for the treatment of metabolic syndrome
IL238064A0 (en)	2015-05-31	Virus-containing formulation and use thereof
IL271352B (en)	2021-04-29	Pharmaceutical composition comprising glutarimide derivatives and use thereof in the treatment of eosinophilic diseases
IL235923B (en)	2018-11-29	Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof
PL2938307T3 (en)	2017-09-29	Absorbent core exhibiting controlled deformation in use and absorbent article comprising said core
GB201411462D0 (en)	2014-08-13	Prebiotic formulations and methods of use
HRP20190080T1 (en)	2019-03-22	INHALATION PROCEDURE AND FORMULATION
PL2842945T3 (en)	2017-04-28	Sulfonamide derivative and medicinal use thereof
SG10201606161UA (en)	2016-09-29	Albumin Formulation and Use
GB201222455D0 (en)	2013-01-30	Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
ZA201501124B (en)	2016-04-28	Trans-clomiphene formulations and uses thereof
IL234906A0 (en)	2014-12-31	Colchicine formulations; methods of making; and methods of use thereof
ZA201402820B (en)	2015-11-25	Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof
SG11201502096VA (en)	2015-04-29	NOVEL EXTRACTS OF CYNARA SCOLYMUS, COFFEA spp. AND OLEA EUROPAEA FOR THE TREATMENT OF METABOLIC SYNDROME
ZA201402452B (en)	2015-09-30	Novel pyrimethanil formulations and uses thereof in the treatment of crops
SI2755669T1 (en)	2017-06-30	Cynara scolymus extracts and their use for the treatment of metabolic syndrome and dyslipidaemia
AP2014007616A0 (en)	2014-05-31	Agrochemical formulation and use thereof
BR112014017217A8 (en)	2017-07-04	pharmaceutical agent and composition
ZA201408053B (en)	2016-04-28	Compositions and methods for the treatment of metabolic syndrome
IL229936B (en)	2019-10-31	Albumin formulation and use
GB201207064D0 (en)	2012-06-06	Pharmaceutical compositions comprising 15-hetre and methods of using the same
ZA201507676B (en)	2017-11-29	Coated phenylephrine particles and use thereof in pharmaceutical formulations
GB201104965D0 (en)	2011-05-11	Gpr119 agonists for use in the treatment or prevention of dyslipidaemia in humans